Correlation of Lipophilicity Descriptors With Pharmacokinetic Parameters of Selected Benzodiazepines
Correlation of Lipophilicity Descriptors With Pharmacokinetic Parameters of Selected Benzodiazepines
Correlation of Lipophilicity Descriptors With Pharmacokinetic Parameters of Selected Benzodiazepines
org
Afr. J. Biomed. Res. Vol.19 (September, 2016); 213- 218
Full Length Research Paper
Correlation of Lipophilicity Descriptors with Pharmacokinetic
Parameters of Selected Benzodiazepines
Adeyemo M.A1 and Idowu S.O1*
1
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria.
ABSTRACT
In early-stage drug discovery science, it is often important to reliably predict the absorption, distribution, metabolism and
elimination (ADME) property of new chemical entities in pipeline, in order to filter molecules that are not drug-like. Several in-
vitro models of lipophilicity profiling as predictor of ADME property have been developed. The validity of lipophilicity
determination based on different descriptors was evaluated using 4 model compounds of the benzodiazepine class; bromazepam,
clonazepam, diazepam and lorazepam. Lipophilicity descriptors describing the retention behaviours of the model compounds
were obtained from three approaches, namely; planar chromatographic determination (i.e. Isocratic chromatographic
hydrophobicity index), calculated log P values (i.e. clog P, ChemAxon), and octanol-water partition coefficient (i.e. log P). These
descriptors were correlated with in-vivo pharmacokinetic parameters - maximum plasma concentration (Cmax), time to reach peak
plasma concentration (Tmax) and area under plasma concentration – time curve (AUC), using the Pearson rank correlation. The
experimental approaches ranked diazepam as most lipophilic while in-silico approach ranked lorazepam as most lipophilic. AUC
and Cmax correlated positively with the lipophilicity descriptors while T max gave negative correlation (except for the in-silico
method) (r = 0.60, -0.74, and -0.25) with lipophilicity descriptors clog P, ICHI and logP respectively. ICHI gave the best
correlation with pharmacokinetic parameters - Cmax (r = 1.0), AUC (r = 0.89) and T max (r = -0.74) The planar chromatographic
platform was shown to be a valid biomembrane model for lipophilicity profiling. The lipophilicity descriptor, ICHI is positively
and strongly correlated with Cmax, and found superior to the correlation of Cmax with time-honoured octanol/water log P. A larger
study is thus warranted to delineate the potential of ICHI for general utility.
Abstracted by:
Bioline International, African Journals online (AJOL), Index Copernicus, African Index Medicus (WHO), Excerpta medica (EMBASE), CAB
Abstracts, SCOPUS, Global Health Abstracts, Asian Science Index, Index Veterinarius
chromatographic techniques like reversed phase planar determined by inear regression analysis (GraphPad Prism
chromatography, high performance liquid chromatography, version 6.0, 2015). The x-intercept (φo) known as the ICHI,
immobilized artificial membrane chromatography (IAM), extrapolated from the graph was used in ranking the
immobilized liposome chromatography (ILC), micellar lipophilicity of the model compounds (Idowu et al, 2009).
electrokinetic chromatography (MEKC) and Bio-partitioning
Micellar Chromatography (BMC) etc. Correlation Analysis: Secondary data obtained from the
Lipophilicity is a critical parameter for central nervous literature (www.drugbank.ca) comprising of the experimental
system agents that are active in vivo (Ewelina, 2013). The octanol - water partition coefficient and calculated log P using
benzodiazepines are among the most commonly prescribed the most popular and widely accepted ChemAxon clog P
centrally acting drugs used as anxiolytics, muscle relaxants, algorithm were pooled together with the experimentally
antiepileptic and as hypnotic agents (Mihic and Harris, 2011); determined chromatographic lipophilicity descriptor, ICHI.
whose pharmacology depends on the compound’s This was correlated with pharmacokinetic parameters like
lipophilicity. Lipophilicity of benzodiazepines has been area under the plasma concentration-time curve (AUC), peak
reported to influence their speed of action; and thus the plasma concentration (Cmax) and time to reach peak plasma
rational choice of the more lipophilic members of the class e.g. concentration (Tmax) which were culled from literature. The
diazepam in eliciting rapid effect in acute conditions (Vinkers correlation analysis of the three lipophilicity descriptors with
et al, 2012). Furthermore, the absorption pharmacokinetic the pharmacokinetic parameters was performed using the
profile indicated that the highly lipophilic benzodiazepines Pearson correlation coefficient as a measure of goodness-of-
penetrate the CNS rapidly with consequent tendency for high correlation between the parameters. All statistical analysis
abuse (Melton and Kirkwood, 2014). was performed by GraphPad Prism version 6.0 for Windows
The validity of lipophilicity measurement methods is (Graph Pad Software, San Diego, CA, www.graphpad.com,
dependent on the extent of similarity of the system to the 2015)
biological membrane architecture (i.e. biomimetic feature)
(Smith et al., 1996). In this paper, we report a comparative RESULTS
evaluation of the correlation of various lipophilicity
descriptors with pharmacokinetic parameters, as a validation The retention behavior of the model compounds depicted by
of the strategies adopted in obtaining the descriptors, using a the linear regression of Rm versus the organic modifier fraction
small chemical library of benzodiazepines (Figure 1). is displayed in Figure 2. The derived lipophilicity parameter
(Isocratic chromatographic hydrophobicity index –ICHI), and
MATERIALS AND METHODS experimental log P values and cLogP values (obtained from
the literature) for the model compounds are shown in Table 1.
Chemicals and Equipment: Diazepam, clonazepam, Correlation analysis between the pharmacokinetic parameters
lorazepam and bromazepam (Secondary reference sample, (Table 2) revealed different levels of correlation with the
British Pharmacopoeia), pre-coated silica gel thin layer lipophilicity descriptors. Figure 3 shows the correlation of the
chromatographic plate (0.2mm, Merck, Germany) , n-hexane lipophilicity descriptors with the bioavailability parameter
(Analar, British Drug House), methanol (Analar, British Drug (AUC) revealing a poor correlation with experimental log P (r
House), liquid paraffin (Analar, British Drug House), Mettler =0.47), negative correlation with clog P (r = -0.47) and fair
H80 analytical balance (UK), UV lamp (254 and 365 nm, correlation with chromatographic ICHI parameter (r = 0.89).
Gallenkamp, U.K.) Correlation between the maximum plasma concentration
Preparation of reversed phase stationary phase: 5% liquid (Cmax) and time for maximum plasma concentration (Tmax) is
paraffin in n-hexane was used to coat the surface of the silica displayed in Figure 4 and 5 respectively.
gel plates (5 x 10cm) by the ascending development method.
Table 1: Lipophilicity index from planar chromatographic
Preparation of the mobile phase: Various concentrations (φ) experiment (ICHI), experimental log P (octanol/water partition) and
comprising of 30, 35, 40, 45, 50, 55, 60, 62.5 and 65% of calculated logP (ACD ChemAxon)
methanol-water mixture was prepared in developing the Lipophilicity descriptors
chromatogram of the model compounds. Model ICHI LogP cLogP
Lipophilicity profiling of the model compounds: Methanolic compound Experimental
solutions (2 µL of 1% w/v) of the model compounds were Bromazepam 0.529 2.05 2.54
spotted on reversed phase plates, and developed in the gradient Clonazepam 0.531 2.41 3.15
Diazepam 0.618 2.82 3.08
series of mobile phase. The retardation factor (Rf) obtained
Lorazepam 0.516 2.39 3.53
was transposed into Rm values (Biagi et al, 1969). Linear plots
of the Rm versus φ were made and the line of best – fit was
Table 2: Mean values of pharmacokinetic parameters of Bromazepam, Clonazepam, Diazepam and Lorazepam (Culled from literature)
AUC (nghr/ml) Cmax (ng/ml) Tmax (hrs)
Bromazepam 2501 (Podilsky et al, 2009) 46 (Podilsky et al, 2009) 1.53 (Podilsky et al, 2009)
Clonazepam 561(Crevoisier et al, 2003) 50 (Sio et al, 1975) 2.5 (Crevoisier et al, 2003)
Diazepam 4430 (Guo et al, 2013) 178 (Guo et al, 2013) 1.25 (Guo et al, 2013)
Lorazepam 405 (Blin et al, 1999) 20 (www.accessdata.fda.gov) 2.37 (Blin et al, 1999)
214 Afr. J. Biomed. Res. Vol. 19, No.3 (September) 2016 Adeyemo and Idowu
Lipophilicity and Pharmacokinetic Parameters of Benzodiazepines
Figure 1:
Chemical structures of the study compounds
DISCUSSION
Figure 2:
Linear regression of the Rm versus the organic modifier Figure 3:
fraction revealing the retention behavior of the model Correlation analysis of the AUC with the 3 lipophilic
compounds descriptors
215 Afr. J. Biomed. Res. Vol. 19, No.3 (September) 2016 Adeyemo and Idowu
Lipophilicity and Pharmacokinetic Parameters of Benzodiazepines
Figure 5:
Figure 4: Correlation analysis of Tmax with the 3 lipophilicity descriptors.
Correlation analysis of Cmax with the 3 lipophilicity descriptors
Nitrogen being a hydrogen bond acceptor, will confer water
This implies that the greater the polarity of a molecule, the solubility, thus making bromazepam less lipophilic than
lower the lipophilicity. Thus, based on structural theory, clonazepam, devoid of an heterocycle albeit with a polar nitro
lorazepam which has a hydroxyl moiety (a hydrogen bond substituent on another phenyl ring. The ranking based on the
donor and acceptor) in the benzodiazepine skeleton is results of the chromatographic method thus corroborate
expected to have the lowest lipophilicity, while diazepam structural theory. On the contrary, the in-silico approach (c log
which has an additional methyl group should be the most P) emphasized the inherent limitation of in-silico approach in
lipophilic. predicting molecular properties, due to inability of computer
Between the two extremes, bromazepam has a nitrogen algorithms to fully account for the 3 dimensional structural
heteroatom in a 6-membered heterocycle (pyridine moiety) details of molecules and lack of parameterization of certain
instead of the phenyl ring in all the other compounds. molecular fragments (Mannhold, 2008). Ranking lorazepam
216 Afr. J. Biomed. Res. Vol. 19, No.3 (September) 2016 Adeyemo and Idowu
Lipophilicity and Pharmacokinetic Parameters of Benzodiazepines
as most lipophilic of the series cannot be supported by drug discovery science. Such a larger study is ongoing in our
structural theory. The closeness of values used in ranking the laboratory.
experimentally determined parameters implies they are more
accurate estimate of lipophilicity than the in silico predictions. Acknowledgement
(Eros et al, 2002) The authors thank Ms. Monsurat Oriyomi Nureni for her
technical assistance
REFERENCES
The area under the plasma concentration-time curve
(AUC) gave a poor correlation (r = 0.47) with experimental Biagi G.L., Barbaro A.M., Gamba M.F., and Guerra M.C. (1969)
log P (octanol-water); fairly good correlation (r = 0.89) with Partition data of penicillins determined by means of reversed phase
the chromatographic ICHI and negative correlation (r = -0.47) thin-layer chromatography Journal of chromatography 41: 371.
with the calculated log P. The peak plasma concentration Cmax Blin O., Jacquet, A., Callamand, S., Jouve, E., Habib, M.,
had a better correlation (r = 0.80) with the experimental log P Gayraud, D., Durand, A., Bruguerolle, B. and Pissano, P. (1999):
Pharmacokinetic-pharmacodynamic analysis of amnesic effects of
(octanol-water), high and positive correlation (r = 1.0) with
lorazepam in healthy volunteers. Journal Clinical Pharmacology
the chromatographic ICHI and negative correlation (-0.13) 48(4): 510–512.
with calculated log P. This underscores the more complex Brunton et al (2008) Goodman and Gilman’s Manual of
partition dynamics of reversed phase chromatographic system Pharmacology and Therapeutics; 11th edition; pg 266; The McGraw
is a better simulation of the biological system. Hence, more Hill Companies: United State of America
reliable and accurate experimentally determined lipophilicity Crevoisier, C., Delisle, M.C., Joseph, I. and Foletti, G. (2003):
descriptor, with improved prediction of pharmacokinetic Comparative single-dose pharmacokinetics of clonazepam following
parameters, should be achievable with increasing biomimetic intravenous, intramuscular and oral administration of healthy
adaptation of reversed phase chromatographic system. volunteers. European Neurology 49 (3):173-7.
Cross S.E., Magnusson B. M., Winckle G., Anissimov Y., Roberts
The Tmax had a reverse correlation pattern with the
M.S (2003): Determination of the effect of Lipophilicity on the in
lipophilicity descriptors, showing a fair correlation ( r = 0.60) vitro permeability and tissue reservoir characteristics of topically
though positive correlation with calculated logP , and applied solutes in human skin layers. J. Invest. Dermatol. 120(5):
negative correlation (r = -0.74 and -0.25) with 759-64.
chromatographic ICHI and the experimental logP (octanol- Eros D., I. Kovesdi I., Orfi L., Takacs-Novak K., Acsady G. and
water). AUC is a measure of bioavailability of the drugs, and Keri G (2002): Reliability of logP prediction based on calculated
it is clearly shown that ICHI gave the highest correlation with molecular descriptors: A critical review. Current Medicinal
bioavailability of the drugs. Negative correlation with T max is Chemistry 9, 1819-1829.
also consistent with the correlation pattern with the two other Ewelina, R., Pajak, K. and Jozwiak, K. (2013): Lipophilicity-
Methods of determination and its role in medicinal chemistry Acta
pharmacokinetic parameters. The more lipophilic member,
Poloniae Pharmaceutica Drug Research 70(1): 3-18.
which has a high Cmax and high AUC achieves the Cmax the Feng L.S., Liu M.L., Wang B., Chai Y., Hao X.Q., Meng S., Guo
fastest (i.e a short Tmax). On the contrary, a positive correlation H.Y (2010): Synthesis and invitro antimycobacterial activity of
found between c log P and T max further indicates the balofloxacin ethylene isatin derivatives. Eur. J. Med. Chem. 45(8),
inaccuracy of the in-silico method. 3407-12.
In conclusion, Lipophilicity measurement is one of the Guo, H., Liu, C., Li, J., Zhang, M., Hu, M., Xu, P., Liu, L. and
most crucial physicochemical parameters in predicting in-vivo Liu, X. (2013): A Mechanistic Physiologically Based
pharmacokinetic (ADME) properties. Experimentally Pharmacokinetic-Enzyme Turnover Model Involving both intestine
determined lipophilicity descriptors i.e. logP (octanol-water) and liver to predict CYP3A induction-mediated drug-drug
interactions. Journal of Pharmaceutical Sciences 102(8)
and chromatographic ICHI gave similar, though slightly
Idowu S. O., Adeyemo M. A., Ogbonna U.I., (2009): Engineering
different ranking of the lipophilicity of the drug molecules, and validation of a novel lipid thin film for biomembrane modeling
underscoring the significance of disparity in the complexity of in lipophilicity determination of drugs and xenobiotics. Journal of
partition process involved in the conventional ‘‘shake-flask” Biological Engineering, 3:14 doi: 10.1186/1754-1611-3-14
and partition (reversed-phase) chromatography models. The International Union of Pure and Applied Chemistry (1997):
result of the correlation analysis revealed that the C max Compendium of ChemicalTerminology, 2nd edn. (the Gold Book).
correlated best with the experimentally determined PAC 69, 1137 Glossary of terms used in computational drug design
lipophilicity data, implying a good in-vivo-in vitro correlation (IUPAC Recommendations).
(IVIVC) that could be used for biopharmaceutical prediction Kennedy T (1997): Managing the drug discovery/development
interface. Drug Discovery Tech. 2, 436-441.
of a new chemical entity. The in-silico parameter, c log P
Kerns E.H., Li, D (2003): Pharmaceutical profiling in drug
generally gave a poor correlation. The chromatographic ICHI discovery. Drug Disc. Today, 8, 316-323.
was also revealed as the better predictor (relative to log P octanol- Lipinski,C.A (2000): Drug-like properties and the causes of poor
water) of the pharmacokinetic parameters - AUC, Cmax, and solubility and poor permeability. J. Pharmacol. & Toxicol. Met., 44,
Tmax, . Since the current study investigated a small chemical 235-249.
library of benzodiazepines, a much larger study is warranted Liu X., Testa B., and Fahr A (2011): Lipophilicity and Its
for pharmacological classes of compounds that have shown Relationship with Passive Drug Permeation. Pharm Research 28:
profound influence of compound lipophilicity on bioactivity 962-977
profile. The findings will also delineate the potential of planar Mannhold R. (2008): Molecular Drug Properties: Measurement and
Prediction. Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim.
chromatographic parameter (ICHI) for general utility in
Melton S.T., Kirkwood C.K (2014): Anxiety Disorders I:
predicting drug pharamacokinetic parameters in early-stage Generalized Anxiety, Panic, and Social Anxiety Disorders. In: DiPiro
217 Afr. J. Biomed. Res. Vol. 19, No.3 (September) 2016 Adeyemo and Idowu
Lipophilicity and Pharmacokinetic Parameters of Benzodiazepines
JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey L. eds. Sio, O., Hvidberg, E.F, Naestoft, J. and Lund, M. (1975):
Pharmacotherapy: A Pathophysiologic Approach, 9th edition, Pharmacokinetics and side-effects of clonazepam and its 7-amino-
Chapter 53. New York, NY: McGraw-Hill; 2014. metabolite in man. European Journal of Clinical Pharmacology 8(3-
Mihic S., Harris R (2011): Hypnotics and Sedatives. In: Brunton 4): 249-54.
L.L, Chabner B.A, Knollmann BC. eds. Goodman & Gilman's The Smith D.A., Jones B.C., and Walker D.K (1996). Design of drugs
Pharmacological Basis of Therapeutics, 12th edition Chapter 17. New involving the concepts and theories of drug metabolism and
York, NY: McGraw-Hill. pharmacokinetics. Med. Res. Rev. 16(3):243-66.
Penzotti, J.E., Landrum, G.A., and Putta, S (2004): Building Van de Waterbeemd H., Testa B (1987): The parametrization of
predictive ADMET models for early decisions in drug discovery. lipophilicity and other structural properties in drug design. In: Testa
Current Opinion in Drug Discovery & Development 7, 49-60. B, editor. Advances in drug research, vol. 16. p. 87–227. London:
Podilsky, G., Berger-Grvllaki, M., Testa, B., Buclin, T., Roulet, Academic Press.
M., Pannatier, A. (2009): The bioavailability of bromazepam, Vinkers, C.H,Tijdink, J.K., Luykx, J.J. and Vis, R. (2012):
omeprazole and paracetamol given by nasogastric feeding tube. Choosing the correct benzodiazepine: mechanism of action and
European Journal of Clinical Pharmacology 65(5):435-42 pharmacokinetics. Ned Tijdschr Geneeskd.
Serda, M., Mrozek-Wilczkiewicz A., Jampilek, J., Pesko M., 155(35):A4900.www.accessdata.fda.gov/drugsatfda_docs/label/.../0
Kralova K., Vejsova, M., Musiol, R,. Ratuszna A. and Polanski 17794s034s035lbl.pd.
J. (2012): Investigation of the Biological Properties of (Hetero) www.drugbank.ca.
Aromatic Thiosemicarbazones. Molecules 17: 13483-13502
218 Afr. J. Biomed. Res. Vol. 19, No.3 (September) 2016 Adeyemo and Idowu